.svg){kind=small}
Mar-2026
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Breez has demonstrated a strong presence in the California market, particularly in the Capsules category, where it has consistently held the top position, except for a brief dip to second place in January 2026. This suggests a solid consumer base and effective market strategies for its capsule products. However, in the Edible category, Breez has not managed to break into the top 40, consistently ranking at 45th place over the past four months. This indicates potential challenges or opportunities for growth in this segment. In the Tincture & Sublingual category, Breez's ranking fluctuated, disappearing from the top 30 in January and March 2026, which might signal volatility or competitive pressures in this niche.
In Illinois, Breez's performance in the Capsules category has been noteworthy, maintaining a strong fourth place in both December 2025 and March 2026. This stability suggests a reliable consumer demand for their capsule products in this region. Conversely, in the Tincture & Sublingual category, Breez was ranked fourth in December 2025 but did not appear in the top 30 in subsequent months, which could indicate a need for strategic adjustments. Additionally, Breez's Vapor Pens have shown a slight upward trend, moving from 87th place in December 2025 to 76th place by March 2026, reflecting a gradual increase in market acceptance or sales efforts. This mixed performance across categories highlights areas of strength and potential growth, as well as segments that may require further focus.
Competitive Landscape
In the competitive landscape of the California cannabis capsules market, Breez has demonstrated resilience and strong performance. Throughout the observed period from December 2025 to March 2026, Breez maintained a leading position, consistently ranking first except for a brief dip to second place in January 2026. This fluctuation coincided with a temporary surge by Level, which briefly overtook Breez in January before returning to the second position. Despite this, Breez's sales figures rebounded in March, indicating a robust recovery and a return to the top rank. Meanwhile, ABX / AbsoluteXtracts consistently held the third position, with sales figures trailing behind both Breez and Level. The competitive dynamics suggest that while Breez faces strong competition, particularly from Level, its ability to regain the top spot highlights its market strength and consumer preference in California's capsules category.
Notable Products
In March 2026, Breez's top-performing product was the Indica Extra Strength Tablet 50-Pack (1000mg) in the Capsules category, maintaining its number one ranking since December 2025 with sales reaching 4154 units. Following closely, the Hybrid Extra-Strength Tablet 50-Pack (1000mg) also retained its second position consistently over the months. The Sativa Extra Strength Tablet 50-Pack (1000mg) held steady in third place, showing a slight increase in sales from the previous month. Notably, the Sativa Royal Mint 20-Pack (100mg) in the Edible category rose to fourth place, surpassing the Original Mint Tin 20-Pack (100mg), which slipped to fifth. These rankings indicate a stable preference for Breez's capsule products, with edibles showing dynamic shifts in consumer interest.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
